{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:17:52Z","timestamp":1790792272465,"version":"4.1.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1126,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:bold>Although annular fibrosis is the hallmark of cirrhosis, other microscopic changes that affect liver function such as sinusoid capillarization or loss of metabolic zonation are common. A sustained virological response (SVR) may halt fibrosis deposition in hepatitis C virus (HCV)-infected patients, but its impact on the other cirrhosis-associated lesions is unknown. The aim of this study was to assess the impact of an SVR on cirrhosis-related histopathological features. Paired pre- and posttreatment liver biopsies from 38 HCV patients with cirrhosis with an SVR were analyzed. Fibrosis was staged using the METAVIR scoring system, and the area of fibrosis was measured using morphometry. Ductular proliferation, metabolic zonation, sinusoid capillarization, and hepatic stellate cell activation were assessed by anti-cytokeratin-7, anti-glutamine synthetase (GS), anti-cytochrome P4502E1 (CYP2E1), anti-CD34, and anti \u03b1-smooth muscle actin (\u03b1SMA). After 61 months from an SVR, cirrhosis regression was observed in 61%, and the collagen content decreased in 89%. Although periportal and lobular necroinflammation vanished, portal inflammation persisted in 66%. Ductular proliferation decreased in 92%. Before treatment, metabolic zonation was lost, as shown by GS and CYP2E1, in 71% and 88%, respectively, with normalization in 79% and 73%, after an SVR. Conversely, no changes in sinusoidal capillarization were observed after treatment, as assessed by CD34 (<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.41) and \u03b1SMA (<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.95). Finally, no differences in all the immunohistochemical scores emerged whether or not cirrhosis persisted.<\/jats:bold>\n                      <jats:bold>Conclusion:<\/jats:bold>\n                      <jats:bold>Cirrhosis regression and decreased fibrosis are frequently observed among HCV patients with cirrhosis with an SVR. Despite ductular proliferation vanishing and lobular zonation restoration, portal inflammation and sinusoidal capillarization may not regress after viral eradication. (HEPATOLOGY 2012)<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.25606","type":"journal-article","created":{"date-parts":[[2012,1,23]],"date-time":"2012-01-23T08:10:24Z","timestamp":1327306224000},"page":"532-543","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":372,"title":["A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis"],"prefix":"10.1097","volume":"56","author":[{"given":"Roberta","family":"D'Ambrosio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Aghemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Rumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bedossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R6-17-20241201","doi-asserted-by":"crossref","first-page":"13031310","DOI":"10.1002\/hep.21176","article-title":"The natural history of compensated cirrhosis due to hepatitis C virus: a 17year cohort study of 214 patients.","volume":"43","author":"Sangiovanni","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R7-17-20241201","doi-asserted-by":"crossref","first-page":"652657","DOI":"10.1016\/j.jhep.2009.12.028","article-title":"Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advenced fibrosis.","volume":"52","author":"Cardoso","year":"2010","journal-title":"J Hepatol"},{"key":"R8-17-20241201","doi-asserted-by":"crossref","first-page":"579587","DOI":"10.1002\/hep.21492","article-title":"Sustained virological response to interferonalpha is associated with improved outcome in HCVrelated cirrhosis: a retrospective study.","volume":"45","author":"Bruno","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R9-17-20241201","doi-asserted-by":"crossref","first-page":"677684","DOI":"10.7326\/0003-4819-147-10-200711200-00003","article-title":"Sustained virological response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.","volume":"147","author":"Veldt","year":"2007","journal-title":"Ann Intern Med"},{"key":"R10-17-20241201","doi-asserted-by":"crossref","first-page":"105114","DOI":"10.7326\/0003-4819-142-2-200501180-00009","article-title":"Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival.","volume":"142","author":"Shiratori","year":"2005","journal-title":"Ann Intern Med"},{"key":"R11-17-20241201","doi-asserted-by":"crossref","first-page":"483491","DOI":"10.1053\/gast.2002.34785","article-title":"Interferon therapy prolonged life expectancy among chronic hepatitis C patients.","volume":"123","author":"Yoshida","year":"2002","journal-title":"Gastroenterology"},{"key":"R12-17-20241201","doi-asserted-by":"crossref","first-page":"20692076","DOI":"10.1002\/hep.23528","article-title":"Sustained virological response prevents the development of esophageal varices in compensated, ChildPugh class A HCVinduced cirrhosis. A twelveyear prospective followup study.","volume":"51","author":"Bruno","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R13-17-20241201","doi-asserted-by":"crossref","first-page":"22692274","DOI":"10.1111\/j.1572-0241.2006.00743.x","article-title":"Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis.","volume":"101","author":"Rincon","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R14-17-20241201","first-page":"677684","article-title":"The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferonribavirin therapy.","volume":"16","author":"DAmbrosio","year":"2011","journal-title":"Antivir Ther"},{"key":"R15-17-20241201","doi-asserted-by":"crossref","first-page":"517524","DOI":"10.7326\/0003-4819-132-7-200004040-00002","article-title":"Histologic improvement of fibrosis in patients with hepatitis C who have sustained virological response to interferon therapy.","volume":"132","author":"Shiratori","year":"2000","journal-title":"Ann Intern Med"},{"key":"R16-17-20241201","doi-asserted-by":"crossref","first-page":"13031313","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.","volume":"122","author":"Poynard","year":"2002","journal-title":"Gastroenterology"},{"key":"R17-17-20241201","first-page":"107112","article-title":"Reversibility of hepatitis C virusrelated cirrhosis.","volume":"1","author":"Pol","year":"35","journal-title":"Hum Pathol"},{"key":"R18-17-20241201","doi-asserted-by":"crossref","first-page":"399403","DOI":"10.7326\/0003-4819-149-6-200809160-00006","article-title":"Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C.","volume":"149","author":"Mallet","year":"2008","journal-title":"Ann Intern Med"},{"key":"R19-17-20241201","doi-asserted-by":"crossref","first-page":"729738","DOI":"10.1002\/hep.22694","article-title":"Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy.","volume":"49","author":"George","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R21-17-20241201","doi-asserted-by":"crossref","first-page":"390400","DOI":"10.1055\/s-2007-991515","article-title":"Hepatic microvasculature in liver injury.","volume":"27","author":"DeLeve","year":"2007","journal-title":"Semin Liv Dis"},{"key":"R22-17-20241201","first-page":"104113","article-title":"The metabolic organization of the adult normal liver: a comparative study of normal, fibrotic and cirrhotic liver tissue.","volume":"24","author":"RacineSamson","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R26-17-20241201","first-page":"1520","article-title":"Inter and intraobserver variation in the assessment of liver biopsy of chronic hepatitis C.","volume":"20","year":"1994","journal-title":"HEPATOLOGY"},{"key":"R27-17-20241201","doi-asserted-by":"crossref","first-page":"289293","DOI":"10.1002\/hep.510240201","article-title":"An alghoritm for the grading of activity in chronic hepatitis C.","volume":"24","author":"Bedossa","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R28-17-20241201","doi-asserted-by":"crossref","first-page":"696699","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis.","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"R29-17-20241201","first-page":"373743","article-title":"A simple micromethod for collagen and total protein determination in formalinfixed paraffinembedded sections.","volume":"33","author":"LopezDe Leon","year":"1985","journal-title":"J Histochem Cytochem"},{"key":"R30-17-20241201","doi-asserted-by":"crossref","first-page":"815818","DOI":"10.1002\/hep.1840050517","article-title":"Measurement of fibrosis in needle liver biopsies: evaluation of a colorimetric method.","volume":"5","author":"Jimenez","year":"1985","journal-title":"HEPATOLOGY"},{"key":"R31-17-20241201","doi-asserted-by":"crossref","first-page":"17391745","DOI":"10.1002\/hep.20130","article-title":"Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers.","volume":"39","author":"Roskams","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R32-17-20241201","first-page":"108115","article-title":"Insulin resistance and necroinflammation drives ductular reaction and epithelialmesenchymal transition in chronic hepatitis C.","volume":"60","author":"SvegliatiBaroni","year":"2011","journal-title":"Gut"},{"key":"R33-17-20241201","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0168-8278(85)80063-5","article-title":"Functional hepatocyte heterogeneity in ammonia metabolism. The intercellular glutamine cycle.","volume":"1","author":"Haussinger","year":"1985","journal-title":"J Hepatol"},{"key":"R35-17-20241201","doi-asserted-by":"crossref","first-page":"437446","DOI":"10.1002\/hep.1840100407","article-title":"The intralobular distribution of ethanolinducible P450IIE1 in rat and human liver.","volume":"10","author":"Tsutsumi","year":"1989","journal-title":"HEPATOLOGY"},{"key":"R36-17-20241201","doi-asserted-by":"crossref","first-page":"393401","DOI":"10.1016\/j.lfs.2010.01.011","article-title":"Cytochrome 3A and 2E1 in human liver tissue: individual variations among normal Japanese subjects.","volume":"86","author":"Hata","year":"2010","journal-title":"Life Sci"},{"key":"R37-17-20241201","doi-asserted-by":"crossref","first-page":"443451","DOI":"10.1007\/BF00274096","article-title":"Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P4503A and glutathioneStransferase.","volume":"99","author":"Fritz","year":"1993","journal-title":"Histochemistry"},{"key":"R38-17-20241201","first-page":"738752","article-title":"Expression of cellcell and cellmatrix adhesion proteins by sinusoidal endothelial cells in the normal and cirrhotic human liver.","volume":"143","author":"Couvelard","year":"1993","journal-title":"Am J Pathol"},{"key":"R39-17-20241201","first-page":"12331242","article-title":"Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers.","volume":"138","author":"SchmittGraff","year":"1991","journal-title":"Am J Pathol"},{"key":"R40-17-20241201","doi-asserted-by":"crossref","first-page":"313325","DOI":"10.1007\/s00418-008-0544-2","article-title":"Vinculin and cellular retinolbinding protein1 are markers for quiescent and activated hepatic stellate cells in formalinfixed paraffin embedded human liver.","volume":"131","author":"Van Rossen","year":"2009","journal-title":"Histochem Cell Biol"},{"key":"R41-17-20241201","first-page":"15991607","article-title":"Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis.","volume":"124","author":"Wanless","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"R42-17-20241201","doi-asserted-by":"crossref","first-page":"902910","DOI":"10.2169\/internalmedicine.43.902","article-title":"Regression of liver fibrosis in cases of chronic liver disease type C: quantitative evaluation by using computed image analysis.","volume":"43","author":"Arima","year":"2004","journal-title":"Intern Med"},{"key":"R43-17-20241201","doi-asserted-by":"crossref","first-page":"489496","DOI":"10.1111\/j.1572-0241.1999.884_m.x","article-title":"Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.","volume":"94","author":"Sakaida","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R44-17-20241201","first-page":"14491457","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C.","volume":"38","author":"Bedossa","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R45-17-20241201","doi-asserted-by":"crossref","first-page":"365373","DOI":"10.1034\/j.1600-0676.2002.01622.x","article-title":"Immunohistochemical evidence for hepatic progenitor cells in liver diseases.","volume":"22","author":"Tan","year":"2002","journal-title":"Liver"},{"key":"R46-17-20241201","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1440-1746.2003.02906.x","article-title":"Oval cellmediated liver regeneration: role of cytokines and growth factors.","volume":"18","author":"Lowes","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"R47-17-20241201","first-page":"259269","article-title":"Ductular reaction and its diagnostic significance.","volume":"15","author":"Roskams","year":"1998","journal-title":"Semin Diagn Pathol"},{"key":"R48-17-20241201","doi-asserted-by":"crossref","first-page":"537541","DOI":"10.1016\/S0002-9440(10)65299-6","article-title":"Oval cell numbers in human chronic liver diseases are directly related to disease severity.","volume":"154","author":"Lowes","year":"1999","journal-title":"Am J Pathol"},{"key":"R49-17-20241201","doi-asserted-by":"crossref","first-page":"809818","DOI":"10.1002\/hep.20650","article-title":"Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis.","volume":"41","author":"Clouston","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R50-17-20241201","doi-asserted-by":"crossref","first-page":"817826","DOI":"10.1111\/j.1478-3231.2006.01306.x","article-title":"Potential role of hepatic progenitor cells expression in cases of chronic hepatitis C and their relation to response to therapy: a clinicopathological study.","volume":"26","author":"Tsamandas","year":"2006","journal-title":"Liver Int"},{"key":"R51-17-20241201","doi-asserted-by":"crossref","first-page":"457466","DOI":"10.1007\/s00428-010-0957-x","article-title":"Hepatic progenitor cells in chronic hepatitis C: a phenomenon of older age and advanced liver disease.","volume":"457","author":"Delladetsima","year":"2010","journal-title":"Virchows Arch"},{"key":"R52-17-20241201","doi-asserted-by":"crossref","first-page":"542551","DOI":"10.1111\/j.1365-2036.2008.03620.x","article-title":"Histological benefit of virological response to peginterferon2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis.","volume":"27","author":"Everson","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R53-17-20241201","doi-asserted-by":"crossref","first-page":"821829","DOI":"10.1053\/j.gastro.2008.05.044","article-title":"Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.","volume":"135","author":"Maylin","year":"2008","journal-title":"Gastroenterology"},{"key":"R54-17-20241201","doi-asserted-by":"crossref","first-page":"365372","DOI":"10.1002\/path.2606","article-title":"Dicer is required for proper liver zonation.","volume":"219","author":"Sekine","year":"2009","journal-title":"J Pathol"},{"key":"R55-17-20241201","doi-asserted-by":"crossref","first-page":"425436","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis.","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R56-17-20241201","doi-asserted-by":"crossref","first-page":"548557","DOI":"10.1136\/gut.48.4.548","article-title":"Apoptosis of hepatic cellate stells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors.","volume":"48","author":"Issa","year":"2001","journal-title":"Gut"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.25606","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201208000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T09:05:16Z","timestamp":1733043916000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201208000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.25606","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717956000.793460955","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717956000.793515301","asserted-by":"object"}]},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}